DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR LIPITOR
Clinical Trials for Lipitor
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00023231 | Pediatric Kidney Transplant Without Calcineurin Inhibitors | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | N/A | 2001-02-01 | The purpose of this study is to see the effect of using drugs other than calcineurin inhibitors to improve the rate of kidney transplant failure. Kidney transplantation can help children with end-stage kidney disease. However, it has been difficult to find treatment for donor graft rejection that does not have a lot of side effects. Researchers hope to find treatments (immunosuppressants) with fewer side effects. One approach is to avoid using calcineurin inhibitors and to try a new drug known as sirolimus instead. Another is to use steroids less often. This study will test whether using sirolimus, fewer steroid treatments, MMF, and certain antibodies will improve long-term graft survival in children receiving kidney transplants from living donors. |
| NCT00024531 | Lipitor as a Treatment for Alzheimer's Disease | Completed | Pfizer | Phase 2 | 2000-10-01 | The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease. |
| NCT00024531 | Lipitor as a Treatment for Alzheimer's Disease | Completed | Institute for the Study of Aging (ISOA) | Phase 2 | 2000-10-01 | The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lipitor
Condition Name
Clinical Trial Locations for Lipitor
Trials by Country
Clinical Trial Progress for Lipitor
Clinical Trial Phase
Clinical Trial Sponsors for Lipitor
Sponsor Name
